JNCE - Jounce Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5156.64M
Enterprise Value 3-59.41M
Trailing P/E N/A
Forward P/E 1-3.68
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)2.70
Price/Book (mrq)1.51
Enterprise Value/Revenue 3-1.02
Enterprise Value/EBITDA 61.65

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Sep 30, 2018


Profit Margin -59.74%
Operating Margin (ttm)-68.34%

Management Effectiveness

Return on Assets (ttm)-9.00%
Return on Equity (ttm)-24.92%

Income Statement

Revenue (ttm)58.09M
Revenue Per Share (ttm)1.79
Quarterly Revenue Growth (yoy)-19.60%
Gross Profit (ttm)38.82M
EBITDA -35.91M
Net Income Avi to Common (ttm)-34.7M
Diluted EPS (ttm)-1.07
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)211.76M
Total Cash Per Share (mrq)6.48
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.07
Book Value Per Share (mrq)3.16

Cash Flow Statement

Operating Cash Flow (ttm)-68.1M
Levered Free Cash Flow (ttm)-2.26M

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3-70.22%
S&P500 52-Week Change 3-5.98%
52 Week High 329.25
52 Week Low 32.66
50-Day Moving Average 33.89
200-Day Moving Average 35.94

Share Statistics

Avg Vol (3 month) 3345.54k
Avg Vol (10 day) 3234.27k
Shares Outstanding 532.7M
Float 19.17M
% Held by Insiders 113.04%
% Held by Institutions 177.41%
Shares Short (Dec 31, 2018) 4685.6k
Short Ratio (Dec 31, 2018) 41.72
Short % of Float (Dec 31, 2018) 44.39%
Short % of Shares Outstanding (Dec 31, 2018) 42.10%
Shares Short (prior month Nov 30, 2018) 41.41M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A